Bioiberica to Trial a New Compound on Human Subjects
BARCELONA: A new compound of animal origin, isolated from the porcine brain and completely developed by Bioiberica investigators, has achieved positive results in slowing down the progression of Alzheimer’s in seven studies using animals.
